Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy

Molecular Nutrition and Food Research

Volumn 59, Issue 2, 2015, Pages 344-354

  Jia, Yaoyao ^a   Kim, Seyoung ^a   Kim, Jiyoung ^a   Kim, Bobae ^a   Wu, Chunyan ^a   Lee, Ji Hae ^a   Jun, Hee jin ^a   Kim, Nahyun ^a   Lee, Dongho ^a   Lee, Sung Joon ^a  

^a Korea University   (South Korea)

Author keywords

Autophagy; Glucose metabolism; Lipid metabolism; PPAR ; Ursolic acid

Indexed keywords

MUS;

ADIPONECTIN; CHOLESTEROL; FATTY ACID; GLUCOSE BLOOD LEVEL; LEPTIN; MAP1LC3 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; MTAP1A PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; TRITERPENE; URSOLIC ACID;

ANIMAL; AUTOPHAGY; BLOOD; C57BL MOUSE; CARBOHYDRATE METABOLISM; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPOGENESIS; LIVER; MALE; METABOLISM; MOUSE;

ADIPONECTIN; ANIMALS; AUTOPHAGY; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CHOLESTEROL; DIET, HIGH-FAT; FATTY ACIDS; INSULIN RESISTANCE; LEPTIN; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; PPAR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES; TRITERPENES;

EID: 84922742510     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400399     Document Type: Article

References (42)

1. Somova, L. O., Nadar, A., Rammanan, P., Shode, F. O., Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 2003, 10, 115-121.
2. Jang, S. M., Yee, S. T., Choi, J., Choi, M. S. et al., Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. Int. Immunopharmacol. 2009, 9, 113-119.
3. Liu, J., Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 1995, 49, 57-68.
4. Azevedo, M. F., Camsari, C., Sa, C. M., Lima, C. F. et al., Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3. Phytother. Res. 2010, 24(Suppl 2), S220-S224.
5. Kim, J., Jang, D. S., Kim, H., Kim, J. S., Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidiaarguta. Arch. Pharmacal Res. 2009, 32, 983-987.
6. Rao, V. S., de Melo, C. L., Queiroz, M. G., Lemos, T. L. et al., Ursolic acid, a pentacyclictriterpene from Sambucusaustralis, prevents abdominal adiposity in mice fed a high-fat diet. J. Med. Food 2011, 14, 1375-1382.
7. Ma, X. H., Zhao, Y. C., Yin, L., Xu, R. L. et al., Studies on the preventive and therapeutic effects of ursolic acid (UA) on acute hepatic injury in rats. Yao xuexuebao 1986, 21, 332-335.
8. Shukla, B., Visen, P. K. S., Patnaik, G. K., Tripathi, S. C. et al., Hepatoprotective activity in the rat of ursolic acid isolated from eucalyptus hybrid. Phytother. Res. 1992, 6, 74-79.
9. Jayaprakasam, B., Olson, L. K., Schutzki, R. E., Tai, M. H. et al., Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J. Agric. Food Chem. 2006, 54, 243-248.
10. Jia, Y., Bhuiyan, M. J. H., Jun, H. J., Lee, J. H. et al., Ursolic acid is a PPAR-alpha agonist that regulates hepatic lipid metabolism. Bioorg. Med. Chem. Lett. 2011, 21, 5876-5880.
11. Desvergne, B., Wahli, W., Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20, 649-688.
12. Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T. et al., Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 1998, 273, 5678-5684.
13. Reddy, J. K., Nonalcoholic steatosis and steatohepatitis - III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis.Am. J. Physiol-Gastr. L. 2001, 281, G1333-G1339.
14. Motojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J. et al., Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J. Biol. Chem. 1998, 273, 16710-16714.
15. Harano, Y., Yasui, K., Toyama, T., Nakajima, T. et al., Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver Int. 2006, 26, 613-620.
16. Nakajima, T., Tanaka, N., Kanbe, H., Hara, A. et al., Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism. Mol. Pharmacol. 2009, 75, 782-792.
17. Leone, T. C., Weinheimer, C. J., Kelly, D. P., A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. USA 1999, 96, 7473-7478.
18. Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J. et al., Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 1999, 103, 1489-1498.
19. Li, A. C., Palinski, W., Peroxisome proliferator-activated receptors: how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis. Annu. Rev. Pharmacol. Toxicol. 2006, 46, 1-39.
20. Choi, A. M., Ryter, S. W., Levine, B., Autophagy in human health and disease. N. Engl. J. Med. 2013, 368, 1845-1846.
21. Wang, K., Klionsky, D. J., Mitochondria removal by autophagy. Autophagy 2011, 7, 297-300.
22. Marino, G., Lopez-Otin, C., Autophagy: molecular mechanisms, physiological functions and relevance in human pathology. Cell. Mol. Life Sci. 2004, 61, 1439-1454.
23. Mizushima, N., Autophagy: process and function. Genes Dev. 2007, 21, 2861-2873.
24. Singh, R., Kaushik, S., Wang, Y., Xiang, Y. et al., Autophagy regulates lipid metabolism. Nature 2009, 458, 1131-1135.
25. Lamark, T., Johansen, T., Aggrephagy: selective disposal of protein aggregates by macroautophagy. Int. J. Cell Biol. 2012, 2012, 736905.
26. Yang, L., Li, P., Fu, S. N., Calay, E. S. et al., Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010, 11, 467-478.
27. Ebato, C., Uchida, T., Arakawa, M., Komatsu, M. et al., Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab. 2008, 8, 325-332.
28. He, C. C., Bassik, M. C., Moresi, V., Sun, K. et al., Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012, 481, 511-515.
29. Chetiveaux, M., Nazih, H., Ferchaud-Roucher, V., Lambert, G. et al., The differential apoA-I enrichment of pre beta(1) and alpha HDL is detectable by gel filtration separation. J. Lipid Res. 2002, 43, 1986-1993.
30. Jia, Y. Y., Kim, J. Y., Jun, H. J., Kim, S. J. et al., Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid. Bba-Mol. Cell Biol. L. 2013, 1831, 698-708.
31. Hoang, M. H., Houng, S. J., Jun, H. J., Lee, J. H. et al., Barley intake induces bile acid excretion by reduced expression of intestinal ASBT and NPC1L1 in C57BL/6J mice. J. Agric. Food Chem. 2011, 59, 6798-6805.
32. Kimura, S., Noda, T., Yoshimori, T., Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007, 3, 452-460.
33. Brennan, A. M., Mantzoros, C. S., Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Nat. Clin. Pract. Endocrinol. Metab. 2006, 2, 318-327.
34. Diez, J. J., Iglesias, P., The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 2003, 148, 293-300.
35. Kunkel, S. D., Elmore, C. J., Bongers, K. S., Ebert, S. M. et al., Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PloS One 2012, 7, e39332.
36. Martin, G., Poirier, H., Hennuyer, N., Crombie, D. et al., Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. J. Biol. Chem. 2000, 275, 12612-12618.
37. Fan, C. Y., Pan, J., Usuda, N., Yeldandi, A. V. et al., Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J. Biol. Chem. 1998, 273, 15639-15645.
38. Teter, S. A., Eggerton, K. P., Scott, S. V., Kim, J. et al., Degradation of lipid vesicles in the yeast vacuole requires function of Cvt17, a putative lipase. J. Biol. Chem. 2001, 276, 2083-2087.
39. Ryder, J. W., Chibalin, A. V., Zierath, J. R., Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle. Acta Physiol. Scand. 2001, 171, 249-257.
40. Seldin, M. M., Lei, X., Tan, S. Y., Stanson, K. P. et al., Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver. J. Biol. Chem. 2013, 28, 36073-36082.
41. Sharp, Z. D., Bartke, A., Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60, 293-300.
42. Yang, Y., Zhao, Z., Liu, Y., Kang, X. et al., Ursolic acid via LKB1-AMPK signaling suppresses oxidative stress and improves liver functions in mice. J. Gastroenterol. Hepatol. 2014, doi: 10.1111/jgh.12723